J&J has boosted its collection of antibody-drug combination treatments by buying Ambrx Biopharma
Merck has bought immuno-oncology biotech Harpoon Therapeutics
AbbVie taps into Neuroscience by officially acquiring Cerevel Therapuetics
AbbVie took the lead as the highest drug ad spender in December 2023
Eli Lilly opposes the use of its diabetes & obesity drugs for cosmetic weight loss
Ozempic, Novo Nordisk's GLP drug, shows no link to suicide ideation
GSK is looking to carve out a RSV market with its new vaccine
Eli Lilly has created a website to make it easier for patients to access their portfolio of diabetes, migraine and obesity medicines
Astella's Gastric cancer therapy rejected by FDA
Nanowear, smart clothing maker, gains FDA approval for an AI-enabled wearable blood pressure monitoring system
The FDA has approved Medtronic's brain stimulator, designed to alleviate symptoms of movement disorders, including Parkinson's and epilepsy.
Medtronic gains European approval to combine their insulin pump with the newest glucose sensor
Florida has received FDA approval to import cheaper drugs from Canada
Real Chemistry has partnered with American Cancer Society (ACS) on an AI-powered and interactive digital experience aimed at cancer patients
Vertex Pharmaceuticals places a hold on their diabetes cell therapy trial after two unrelated patient deaths
Oryzon Genomics will seek FDA advice after their treatment failed to show improvement in Borderline Personality Disorder
%402x.svg){kind=icon}
.png)
%402x.svg){kind=icon}
